A children’s skincare line is not an adult formula with gentler copy. It changes the formulation brief, the safety evidence regulators expect, and the claim language you are allowed to use — and those expectations are not the same from one market to the next. The practical answer: design the product for the strictest market you intend to sell in, keep the ingredient list short, and confirm the regulatory path (filing versus registration, labelling, safety assessment) before you commission samples.
The same line-building discipline applies to other single-category launches we have written about, from a body care line to a men’s grooming line.
What makes a product a "children’s" cosmetic?
The definition matters because it decides which rules apply. In China, children’s cosmetics are defined as products intended for users aged 12 and under; items labelled "family use" or carrying "baby" wording, and products that imply child use through imagery, are treated the same way. The United States has no separate federal children’s-cosmetics statute, but cosmetics marketed to children under 12 can fall under the Consumer Product Safety Improvement Act (CPSIA) for lead limits. The European Union applies the general Cosmetic Products Regulation (EC) 1223/2009 to children’s products without a dedicated children’s-only layer.
Why this matters: the moment a product is positioned for children, buyers, retailers and regulators read the formula and the claims more strictly. Building for that scrutiny from day one is cheaper than reformulating later.
How should a children’s skincare line formula differ from an adult product?
The accepted approach is "fewer, gentler" rather than "weaker." Practical moves include:
- A short ingredient list, focused on the function the product actually performs.
- Little or no fragrance; this is the single biggest lever for reducing sensitization risk in kids’ cosmetics.
- A milder preservation system, since preservative choice is judged carefully for young skin and fewer actives make the system easier to balance.
- A pH close to skin, and no unnecessary essential oils or botanical extracts added for marketing.
- Avoiding strong actives that are common in adult routines — retinoids, high-strength acid exfoliants and skin-lightening agents are not appropriate claims for a children’s line.
This aligns with China’s stated principle for children’s cosmetics: safety first, efficacy only where needed, and a minimal formula. Other markets express the same idea through their safety-assessment expectations rather than a single published rule, so the formula you ship should hold up under each one.
Which claims are off-limits for a children’s line?
Keep the vocabulary to what a cosmetic can honestly support: cleanse, moisturize, help protect (sunscreen, with the right positioning), and soothe. Avoid claims that imply a drug-style result — anti-aging, whitening or lightening, acne care, or any "medicinal" framing. Even softer words such as "hypoallergenic" or "dermatologically tested" are not self-proving; they need substantiation behind them.
The safest habit is to write the claim, then ask whether a study or a recognised test method actually backs it. If the answer is no, drop it. That discipline protects the brand if a market later asks for proof.
What do regulators expect in each market?
Requirements vary by market, product type and wording, so confirm the specifics for your target before artwork is final. The outline below is a planning reference, not a compliance certificate.
| Market | Framework | What stands out for children’s products |
|---|---|---|
| China | 儿童化妆品监督管理规定 (effective 2022-01-01) | Dedicated children’s rules; safety assessment and toxicology expected; the "small gold shield" (小金盾) label is required on the pack; sunscreen is a special cosmetic needing registration, while other categories are filed as ordinary cosmetics. |
| European Union | Regulation (EC) 1223/2009 | Responsible person and safety assessment required; 26 fragrance allergens must be individually labelled above set thresholds (0.01% rinse-off, 0.001% leave-on), with the list under review for expansion. |
| United States | FD&C Act + MoCRA (2022) | Cosmetics and ingredients (except color additives) need no FDA pre-market approval; MoCRA adds facility registration, product listing, adverse-event reporting and safety substantiation; CPSIA lead limits can apply to products for under-12s. |
Note the difference between a law and a voluntary label: the EU Ecolabel, for example, asks children’s products to be fragrance-free, but that is an eco-label choice, not a general legal requirement. Keep the two separate when you brief your team.
What testing and documents should you plan for?
Budget for the evidence package early, because it sits on the critical path. Commonly expected items include stability testing, preservative efficacy (challenge) testing, a safety assessment, microbial limits, and heavy-metal screening (lead, cadmium, mercury, arsenic) against the relevant market limits. Patch testing may support milder claims. Timelines depend on the product, the protocol and the market, so treat any single number as a planning reference rather than a guarantee.
What should a brand prepare before talking to a manufacturer?
A clear brief shortens the whole project. Bring:
- Target age band (infants under 3 need extra caution) and the markets you will sell in.
- The claim list you want, so the formulator can design within it.
- Ingredient restrictions — fragrance-free, preservative preferences, banned actives.
- Packaging notes: avoid small parts, consider child-resistant or tamper-evident closures, and design to discourage accidental ingestion.
- Label copy, so regulatory review can start together with formulation.
Ask the manufacturer directly: which markets can this formula be documented for, what safety assessment do you provide, and where does the lead time actually sit — filling or component supply?
Building a children’s line rewards discipline more than cleverness. If you scope the formula, the claims and the evidence together, the launch is easier to defend in every market you enter. Our team runs OEM and ODM skincare programs and can review your brief against real production and documentation constraints before you commit to sampling.